A case study in how market research has helped us better understand the treatment of a rare disease in oncology
The latest market research case study we conducted is about rare disease treatments in oncology with the aim to improve patient outcomes.
We frequently hear from M3 panel members that they participate in paid healthcare market research to help progress research into potential future treatments, often in overlooked, and underfunded therapy areas.
This was particularly true in this case study, where M3 recruited oncology panelists to take part in research into a very low incidence rate condition – with the 20% of oncologists treating the condition only seeing 1-2 cases per year on average. However, their enthusiasm for helping to improve patient outcomes saw us open up this research to 700 participants globally, delivering actionable insights for the pharmaceutical manufacturer client.
Interested in more healthcare case-studies?
Did you find this “Rare disease treatments In oncology” study interesting?
You can visit our section M3 Case-studies in the Media, or read the results of our latest healthcare market research studies: